Results 51 to 60 of about 13,710 (215)

Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCT

Health Technology Assessment, 2021
Introduction: Unless women start effective contraception after using emergency contraception, they remain at risk of unintended pregnancy. Most women in the UK obtain emergency contraception from community pharmacies that are unable to provide ongoing ...
Sharon T Cameron, Anna Glasier, Lisa McDaid, Andrew Radley, Susan Patterson, Paula Baraitser, Judith Stephenson, Richard Gilson, Claire Battison, Kathleen Cowle, Thenmalar Vadiveloo, Anne Johnstone, Alessandra Morelli, Beatriz Goulao, Mark Forrest, Alison McDonald, John Norrie   +16 more
doaj   +1 more source

Hormone therapy (HT) in women with premature ovarian insufficiency or early menopause: Time to think of a new paradigm for healthy aging. A joint FIGO and IMS position paper

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Premature ovarian insufficiency (POI) and early menopause (EM) affect millions of women worldwide. Compared with normal menopause, they confer a longer duration of estrogen deficiency and are associated not only with a shorter lifespan, but with a reduced healthspan, owing to an increased risk of cardiovascular, skeletal, cognitive and ...
Chiara Benedetto, Suvarna S. Khadilkar, Rossella E. Nappi, Andrea R. Genazzani, Federica Frezet, Laura Cucinella, Hema Divakar, Panagiotis Anagnostis, Nick Panay   +8 more
wiley   +1 more source

Controlling Levonorgestrel Binding and Release in a Multi-Purpose Prevention Technology Vaginal Ring Device [PDF]

, 2016
Despite a long history of incorporating steroids into silicone elastomers for drug delivery applications, little is presently known about the propensity for irreversible drug binding in these systems.
Boyd, Peter, McCoy, Clare F.; id_orcid, Kumar, Sandeep, Brimer, Andrew N., Murphy, Diarmaid J., Holt, Jonathon D. S., Blanda, Wendy, Malcolm, R. Karl; id_orcid   +7 more
core   +1 more source

Treatment of unacceptable bleeding in long-term users of 52-mg levonorgestrel intrauterine device: a prospective observational studyAJOG Global Reports at a Glance

AJOG Global Reports
BACKGROUND: In the first month after the insertion of the 52-mg levonorgestrel intrauterine device, irregular vaginal bleeding often occurs. In 6% to 18% of 52-mg levonorgestrel intrauterine device users, irregular vaginal bleeding reoccurs or continues ...
Patty A.H.H. van der Heijden, MD, Karlijn A. Röttgering, Tamara J. Oderkerk, MD, Jeanne P. Dieleman, Arianne C. Lim, PhD, Marlies Y. Bongers, PhD, Peggy M.A.J. Geomini, PhD   +6 more
doaj   +1 more source

The not so over-the-counter status of emergency contraception in Ontario: A mixed methods study with pharmacists

FACETS, 2017
Introduction: In Canada, the progestin-only dedicated pill is the most widely used method of emergency contraception (EC). This method gained over-the-counter status in Ontario in 2008.
Andréanne Chaumont, Angel M. Foster
doaj   +1 more source

Levonorgestrel as a Potential Trigger of Acute Bilateral Central Serous Chorioretinopathy: Case Report

Case Reports in Ophthalmology, 2023
This is a first ever report describing a case of acute bilateral central serous chorioretinopathy which developed shortly after the consumption of levonorgestrel as emergency contraception. A 27-year-old female patient visited the emergency department of
Vedran Nemet
doaj   +1 more source

Patient reported outcomes and results of endometrial balloon ablation for the treatment of heavy menstrual bleeding: A single center observational cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Heavy menstrual bleeding is one of the most common gynecologic disorders among women of reproductive age and has a significant impact on their physical, psychological, and social well‐being. Although international guidelines recommend medical therapy as the first‐line treatment, it may prove ineffective, poorly tolerated, or ...
Jonas Rudaitis, Patricija Marozaite, Egle Bareikiene, Vilius Rudaitis   +3 more
wiley   +1 more source

Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery

Pharmaceutics, 2020
Following oral administration, the bioavailability of progestogens is very low and highly variable, in part due to metabolism by cytochrome P450 enzymes found in the mucosa of the small intestine.
Zoe Coombes, Vipul Yadav, Laura E. McCoubrey, Cristina Freire, Abdul W. Basit, R. Steven Conlan, Deyarina Gonzalez   +6 more
doaj   +1 more source

FIGO statement on emergency contraception

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Emergency contraception remains an essential component of comprehensive contraceptive care and reproductive autonomy. Despite being safe, highly effective, and associated with almost no absolute medical contraindications or age limits, emergency contraception is often underutilized due to systemic barriers, limited access, persistent ...
Mikaela Koch, Asha Kasliwal, James Kiarie, Nasser Elkholy, Azra Ahsan, Aparna Sridhar   +5 more
wiley   +1 more source

Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996‐2023: An Observational Study of the Welsh Population

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews, Arron Lacey, Kate Bache, Emma J. Kidd   +3 more
wiley   +1 more source